Prostate Cancer Treatment And Research
52 researchers across 6 institutions
Researchers investigate prostate cancer from multiple perspectives, seeking to improve prevention, diagnosis, and treatment. Studies explore the molecular mechanisms driving cancer development and progression, including genetic mutations and cellular signaling pathways. This work involves laboratory investigations using cell cultures and animal models, as well as clinical studies analyzing patient data. Key areas of focus include developing novel therapeutic agents, understanding drug resistance, and evaluating the effectiveness of different treatment modalities, such as radiation therapy and immunotherapy. Diagnostic advancements are also a significant component, with research into new imaging techniques and biomarkers for earlier and more accurate detection.
Given Arkansas’s demographic profile, research into prostate cancer is particularly relevant to the health and well-being of its citizens. The state experiences disproportionately high rates of prostate cancer incidence and mortality, making efforts to understand the disease and develop effective interventions a public health priority. Investigations into health disparities and outcomes are crucial for identifying and addressing factors that contribute to these statistics within the state's population. Understanding the genetic and environmental influences on prostate cancer risk and progression in Arkansas is a key objective.
This research area benefits from collaborations across numerous disciplines. Connections are made with fields such as cancer-related molecular mechanisms, medical imaging, pharmacology, immunology, and health outcomes research. This interdisciplinary approach is supported by researchers at multiple institutions across Arkansas, fostering a broad base of expertise and engagement.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Shiv Srivastava | UAMS | 64 | 15,057 | High Impact | |
| Deukwoo Kwon | UAMS | 40 | 5,057 | ||
| Shi‐Ming Tu | UAMS | 37 | 5,110 | High Impact | |
| Zhiqiang Qin | UAMS | 24 | 1,836 | High Impact | |
| Alan B. Diekman | UAMS | 22 | 1,664 | High Impact | |
| S. Chowdhury | Arkansas State University | 20 | 2,028 | ||
| Ali Tourchi | UAMS | 16 | 778 | ||
| Mason J. Belue | UAMS | 15 | 615 | ||
| Jason Martin | University of Arkansas | 13 | 1,318 | Grants | |
| Daniel T. Sloper | NCTR | 12 | 440 | ||
| Roni M. Cox | UAMS | 12 | 553 | ||
| Divya Nimma | Arkansas Tech University | 11 | 499 | ||
| Chengzhong Cai | NCTR | 11 | 407 | ||
| Paul Rogers | NCTR | 9 | 354 | ||
| Sergio A. Cortés-Ramírez | UAMS | 9 | 264 | ||
| Sanjay Maraboyina | UAMS | 9 | 255 | ||
| Alberto Losada-García | UAMS | 9 | 229 | ||
| Lora J. Rogers | UAMS | 9 | 229 | ||
| Robert F. Donnell | UAMS | 8 | 1,719 | ||
| Jackson W. Massey | UAMS | 8 | 233 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Johns Hopkins University 4,045
- 2 Memorial Sloan Kettering Cancer Center 3,986
- 3 Dana-Farber Cancer Institute 3,190
- 4 Harvard University 3,110
- 5 University of California, San Francisco 2,958
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Prostate Cancer Treatment And Research.